Global Electronic Prescription Service Market Strategic Research Report

Scope of the Report

The global Electronic Prescription Service market size is predicted to grow from US$ 144 million in 2025 to US$ 205 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.

Electronic Prescription Service refers to the digital management of the entire prescription process, from issuance and circulation to review, dispensing, and settlement, through an information system. Doctors issue prescriptions in the medical system, which are then uploaded to a regional or national prescription-sharing platform after electronic signature. Patients can choose to pick up their medication at a pharmacy using their identity information or authorization code, or have it delivered by the platform. This service improves medication convenience, reduces the risk of loss or tampering with paper prescriptions, and lowers medication errors through system-assisted prescription review. It is widely used in chronic disease follow-up visits, telemedicine, primary healthcare institutions, and retail pharmacies. It is a key link in achieving the separation of prescribing and dispensing, prescription outflow, and a closed loop for internet-based healthcare.

The global Electronic Prescription Service (EPS) market exhibits a pattern of North America leading, rapid adoption in Europe, and emerging growth in the Asia-Pacific region. North America (especially the United States) is the most mature market for EPS, benefiting from the HITECH (Healthcare Information Technology for Economic and Clinical Health) Act and EPCS (Electronic Prescription Controlled Substances) regulations. Leading platforms connect the vast majority of pharmacies and doctors across the US. Europe, with the UK's NHS EPS and the Nordic countries serving as benchmarks, has achieved integrated prescription circulation and drug delivery. The Asia-Pacific region is experiencing rapid growth, with China promoting the outflow of EPS through its "Internet + Healthcare" policy, particularly evident in chronic disease follow-up visits and retail pharmacies.

Future trends include: linkage between EPS and health insurance payments, AI-assisted prescription review, cross-border EPS (medical tourism), and blockchain-based prescription tamper-proofing technology. Key obstacles include: risks associated with verifying prescription authenticity, inconsistent system standards across regions, differences in acceptance among doctors and pharmacists, and concerns about patient privacy. Dynamically, the US DEA is advancing the permanent remote EPS for controlled drugs, and many regions in China are building EPS circulation platforms, with retail pharmacies accelerating their integration with prescription sharing platforms.

This report presents a comprehensive overview of the global Electronic Prescription Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• General Medication Prescription Service
• Antimicrobial Medication Prescription Service
• Chronic Disease Medication Prescription Service
• Others

Segment by User Type

• Outpatient Prescription Service
• Inpatient Prescription Service
• Internet Hospital Prescription Service
• Others

Segment by Prescription Processing Capacity

• Prescription Processing Capacity: ≤ 500
• Prescription Processing Capacity: 500–5,000
• Prescription Processing Capacity: ≥ 5,000

Segment by Application

• Hospital
• Pharmacy
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Electronic Prescription Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Pharmacy, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact